We want to identify really useful peptides that can be leveraged and advanced as treatment for human diseases for which there is no solution at the moment. One potential prospect is MOTs-C, which Cohen discovered and has studied in Phase 1A and Phase 1B trials
Administration Guide AOD-9604 is administered via subcutaneous injection, the same method used for insulin and many other peptide therapies
The default protocol I prescribe is at-home, subcutaneous or intramuscular
It accelerates tendon fibroblast outgrowth, increases cell survival under stress, and promotes cell migration, likely through the activation of the FAK-paxillin pathway
Website information, calculators, guides, and educational resources are provided for general informational purposes only
For anyone in Miami weighing it, the most useful thing is accurate information: what it does, what it does not, and what responsible supervision should look like